BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
11.42
-0.26 (-2.23%)
At close: Aug 1, 2025, 4:00 PM
12.00
+0.58 (5.08%)
After-hours: Aug 1, 2025, 7:13 PM EDT

Company Description

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally.

It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases.

The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

BrainsWay Ltd.
BrainsWay logo
CountryIsrael
Founded2003
IPO DateApr 17, 2019
IndustryMedical Devices
SectorHealthcare
Employees120
CEOHadar Levy

Contact Details

Address:
16 Hartum St, Har Hotzvim
Jerusalem, 9777516
Israel
Phone972 2 582 4030
Websitebrainsway.com

Stock Details

Ticker SymbolBWAY
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$11.00
CIK Code0001076643
CUSIP Number10501L106
ISIN NumberUS10501L1061
Employer ID04-3285165
SIC Code7389

Key Executives

NamePosition
Hadar LevyChief Executive Officer
Dr. David Zacut M.D.Co-Founder and Vice-Chairman
Avner HagaiFounder and Director
Prof. Abraham Zangen Ph.D.Co-Founder, Member of Scientific Advisory Board and Director
Ido MaromChief Financial Officer
Ross MitchellVice President of Global Marketing
Dr. Colleen Hanlon Ph.D.Vice President of Medical Affairs
Michael CohenVice President of US Sales
Dr. Yiftach Roth Ph.D.Founder and Chief Scientific Officer
Dor HagaiVice President of Operations

Latest SEC Filings

DateTypeTitle
Mar 10, 2010REVOKEDFiling
Sep 10, 20014Statement of changes in beneficial ownership of securities
Sep 5, 2001SC 13D/A[Amend] General statement of acquisition of beneficial ownership
Sep 5, 2001SC 13D/A[Amend] General statement of acquisition of beneficial ownership
Sep 5, 20018-KCurrent Report
Aug 15, 2001NT 10-QNotification of inability to timely file Form 10-Q or 10-QSB
Aug 8, 20014Statement of changes in beneficial ownership of securities
Aug 8, 2001SC 13D/A[Amend] General statement of acquisition of beneficial ownership
Jul 5, 200110-KAnnual Report
Jun 27, 20018-KCurrent Report